Pharma dodges a bullet, for now
World of DTC Marketing
NOVEMBER 2, 2021
Medicare’s innovation center may be the best avenue for lowering drug costs if provisions empowering government price negotiation don’t’ make it into a sweeping domestic spending package. One such model could include using value-based payments for Medicare Part B.
Let's personalize your content